Clinical Trials Directory

Trials / Completed

CompletedNCT02411461

Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Accepted

Summary

Pseudohypoparathyroidism type 1a (PHP1a) is a rare disease that causes childhood obesity and learning difficulties. This study will investigate eating behaviors and perform cognitive testing on children with PHP1a. The investigators will compare their results to those of healthy siblings and other obese children.

Detailed description

Pseudohypoparathyroidism type 1a (PHP1a) is a genetic disorder that causes early-onset, syndromic obesity and cognitive impairment. This study aims to evaluate eating behaviors, cognition and executive function in children with PHP1a, compared with healthy siblings and matched obese controls.

Conditions

Timeline

Start date
2014-12-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2015-04-08
Last updated
2019-11-13
Results posted
2018-06-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02411461. Inclusion in this directory is not an endorsement.